HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A infant case of rhabdomyosarcoma arising from the left iliac region with complete remission for 2 years after combination therapy].

Abstract
A case of rhabdomyosarcoma in a 14-year-female is reported herein. The patient developed left inguinal pain and tumor. She was initially seen by her local medical doctor, who biopsied her left inguinal tumor with a pathological report of malignancy. She was referred to the Ryukyu University Hospital in July, 1990. CT and MRI demonstrated a large tumor 10 cm in diameter arising from the left iliac region. The tumor was extirpated and the pathological report indicated rhabdomyosarcoma (alveolar type). The patient was treated with VAC chemotherapy and local irradiation. Her course has been uneventful for the past 2 years without any clinical manifestation of recurrence since surgery.
AuthorsM Shimabuku, Y Muto, A Hokama, F Tokumine, K China, T Gushiken, S Sonan, K Hirayama, T Toda
JournalGan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 20 Issue 5 Pg. 657-60 (Apr 1993) ISSN: 0385-0684 [Print] Japan
PMID8470926 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Dactinomycin
  • Vincristine
  • Cyclophosphamide
Topics
  • Adolescent
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Chemotherapy, Adjuvant
  • Combined Modality Therapy
  • Cyclophosphamide (administration & dosage)
  • Dactinomycin (administration & dosage)
  • Female
  • Humans
  • Ilium
  • Remission Induction
  • Rhabdomyosarcoma (drug therapy, radiotherapy, surgery)
  • Soft Tissue Neoplasms (drug therapy, radiotherapy, surgery)
  • Vincristine (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: